The Journal of Immunology, Vol 157, Issue 7 3200-3206, Copyright © 1996 by American Association of Immunologists

ARTICLES

Autoantibodies to ribosomal P antigens with immune complex glomerulonephritis in SJL mice treated with pristane

M Satoh, KJ Hamilton, AK Ajmani, X Dong, J Wang, YS Kanwar and WH Reeves
Department of Medicine, University of North Carolina, Chapel Hill 27599, USA.

BALB/c ByJ mice develop a lupus-like syndrome characterized by anti- nRNP/Sm and Su autoantibodies and immune complex glomerulonephritis after a single i.p. pristane injection. In contrast, mercuric chloride induces anti-fibrillarin Abs only in SJL and other H-2s mice, and not in BALB/c (H-2d) mice. In the present study, the specificities of autoantibodies induced by pristane and HgCl2 were compared in SJL and BALB/c mice to examine whether these strains are "programmed" to make different sets of autoantibodies in response to nonspecific immune stimulation. Unexpectedly, the predominant autoantibodies induced by pristane in SJL mice were neither those characteristic of HgCl2-treated SJL mice nor those associated with pristane-induced disease in BALB/c mice but, rather, anti-ribosomal P, another lupus-related specificity. The autoantibodies were strongly reactive with the C-terminal 22 amino acids of the ribosomal P2 protein, indicating that they exhibited similar fine specificities to anti-P Abs in human SLE and MRL/Ipr mice. Like BALB/c mice, pristane-treated SJL mice developed severe glomerulonephritis characterized by proteinuria, mesangial proliferation, and glomerular immune complex deposits. This is the first evidence that the induction of a lupus-like syndrome by pristane is not restricted to BALB/c mice. The predominance of anti-P Abs in SJL mice contrasts sharply with the predominance of anti-nRNP/Sm and Su, in pristane-treated BALB/c mice, even though the renal lesions were similar in both strains. The data suggest that H-2s does not program mice to produce anti-fibrillarin Abs in response to nonspecific immune stimulation, arguing that autoantibody induction by pristane involves Ag-specific mechanisms.

This article has been cited by other articles:

				V. R. Chowdhary, J. P. Grande, H. S. Luthra, and C. S. David Characterization of haemorrhagic pulmonary capillaritis: another manifestation of Pristane-induced lupus Rheumatology, September 1, 2007; 46(9): 1405 - 1410. [Abstract] [Full Text] [PDF]

				Y. Kuroda, J. Akaogi, D. C. Nacionales, S. C. Wasdo, N. J. Szabo, W. H. Reeves, and M. Satoh Distinctive Patterns of Autoimmune Response Induced by Different Types of Mineral Oil Toxicol. Sci., April 1, 2004; 78(2): 222 - 228. [Abstract] [Full Text] [PDF]

				I Takeda, K Rayno, F B Movafagh, M Wolfson-Reichlin, and M Reichlin Dual binding capabilities of anti-double-stranded DNA antibodies and anti-ribosomal phosphoprotein (P) antibodies Lupus, December 1, 2001; 10(12): 857 - 865. [Abstract] [PDF]

				J. O. Naim, M. Satoh, N. A. Buehner, K. M. L. Ippolito, H. Yoshida, D. Nusz, L. Kurtelawicz, S. F. Cramer, and W. H. Reeves Induction of Hypergammaglobulinemia and Macrophage Activation by Silicone Gels and Oils in Female A.SW Mice Clin. Vaccine Immunol., May 1, 2000; 7(3): 366 - 370. [Abstract] [Full Text] [PDF]

				J. H. Freed, A. Marrs, J. VanderWall, P. L. Cohen, and R. A. Eisenberg MHC Class II-Bound Self Peptides from Autoimmune MRL/lpr Mice Reveal Potential T Cell Epitopes for Autoantibody Production in Murine Systemic Lupus Erythematosus J. Immunol., May 1, 2000; 164(9): 4697 - 4705. [Abstract] [Full Text] [PDF]

				M. Satoh, V. M. Shaheen, P. N. Kao, T. Okano, M. Shaw, H. Yoshida, H. B. Richards, and W. H. Reeves Autoantibodies Define a Family of Proteins with Conserved Double-stranded RNA-binding Domains as Well as DNA Binding Activity J. Biol. Chem., December 3, 1999; 274(49): 34598 - 34604. [Abstract] [Full Text] [PDF]

				H. B. Richards, M. Satoh, M. Shaw, C. Libert, V. Poli, and W. H. Reeves Interleukin 6 Dependence of Anti-DNA Antibody Production: Evidence for Two Pathways of Autoantibody Formation in Pristane-induced Lupus J. Exp. Med., September 7, 1998; 188(5): 985 - 990. [Abstract] [Full Text] [PDF]